title: Parathyroid hormone (PTH)/PTH-related protein receptor messenger ribonucleic acid expression and PTH response in a rat model of secondary hyperparathyroidism associated with vitamin D deficiency.
abstract: The aim of the present work was to characterize at the molecular level the mechanism of PTH resistance in a rat model of secondary hyperparathyroidism resulting from vitamin D deprivation. PTH/PTH-related protein (PTHrp) receptor messenger RNA (mRNA) expression, assayed by ribonuclease protection analysis, was studied in the kidney, femoral epi/metaphysis, and diaphysis. In addition, in the kidney, PTH/PTHrp receptor mRNA expression was correlated to receptor function by measuring adenyl cyclase activity in crude renal membranes after stimulation by PTH (10(-10) - 10(-6) M), forskolin (0.1 and 0.2 mM), NaF (5 and 10 mM), and isoproterenol (1 and 10 microM). Four groups of rats were studied to investigate the effects of calcium, PTH, and/or vitamin D status. The first group received a control diet (D+D+). The second group received a diet deficient in vitamin D until death (D-D-). In the two other groups that also received a vitamin D-deficient diet, the hypocalcemia and the hyperparathyroidism were later corrected, by either vitamin D supplementation (D-D+) or lactose and high calcium diet (D-Ca+), 1 week before death. The results revealed a 2-fold decrease in the PTH-induced adenyl cyclase activity of the renal membranes in the D-D- rats compared to those in the three other groups. There was no significant difference in the four groups in adenyl cyclase activity stimulated by forskolin, NaF, and isoproterenol. The decrease in PTH-induced adenyl cyclase activity was associated with an approximately 2-fold increase in PTH/PTHrp receptor mRNA expression in the kidneys of the D-D- rats compared to controls. Normalization of PTH/PTHrp receptor mRNA expression was observed after vitamin D supplementation (D-D+ rats), but not after correction of the hypocalcemia and secondary hyperparathyroidism by oral lactose and calcium supplementation. In the epi/metaphysis, an approximately 2-fold increase in PTH/PTHrp receptor mRNA was also observed in the D-D- rats compared to the controls; this increase was partially corrected upon normalization of the calcemia and PTH levels with either vitamin D (D-D+ group) or lactose/calcium (D-Ca+ group). In the diaphysis, no change in the expression of PTH/PTHrp receptor mRNA was observed in any group.(ABSTRACT TRUNCATED AT 400 WORDS)
authors.affiliation: INSERM U-426, Faculté de Médecine Xavier Bichat, Paris, France.
authors.forename: G
authors.initials: G
authors.lastname: Turner
authors.forename: C
authors.initials: C
authors.lastname: Coureau
authors.forename: M R
authors.initials: MR
authors.lastname: Rabin
authors.forename: B
authors.initials: B
authors.lastname: Escoubet
authors.forename: M
authors.initials: M
authors.lastname: Hruby
authors.forename: O
authors.initials: O
authors.lastname: Walrant
authors.forename: C
authors.initials: C
authors.lastname: Silve
mesh_terms: D000262:Adenylyl Cyclases / Q000032:analysis / Q000502:physiology; D000818:Animals; D002118:Calcium / Q000097:blood / Q000378:metabolism / Q000494:pharmacology; D002462:Cell Membrane / Q000737:chemistry / Q000648:ultrastructure; D005576:Colforsin / Q000494:pharmacology; D018483:Diaphyses / Q000737:chemistry / Q000378:metabolism / Q000648:ultrastructure; D004195:Disease Models, Animal; D005269:Femur / Q000737:chemistry / Q000378:metabolism / Q000648:ultrastructure; D005527:Food, Fortified; D006962:Hyperparathyroidism, Secondary / Q000097:blood / Q000209:etiology / Q000378:metabolism*; D007545:Isoproterenol / Q000494:pharmacology; D007668:Kidney / Q000737:chemistry / Q000648:ultrastructure; D007785:Lactose / Q000494:pharmacology; D008297:Male; D010281:Parathyroid Hormone / Q000097:blood / Q000378:metabolism*; D010710:Phosphates / Q000097:blood; D012333:RNA, Messenger / Q000032:analysis* / Q000235:genetics; D051381:Rats; D017208:Rats, Wistar; D044168:Receptor, Parathyroid Hormone, Type 1; D018016:Receptors, Parathyroid Hormone / Q000235:genetics* / Q000378:metabolism; D012969:Sodium Fluoride / Q000494:pharmacology; D014807:Vitamin D / Q000494:pharmacology; D014808:Vitamin D Deficiency / Q000150:complications*
chemical_list: D010281:Parathyroid Hormone; D010710:Phosphates; D012333:RNA, Messenger; D044168:Receptor, Parathyroid Hormone, Type 1; D018016:Receptors, Parathyroid Hormone; D014807:Vitamin D; D005576:Colforsin; D012969:Sodium Fluoride; D000262:Adenylyl Cyclases; D007785:Lactose; D007545:Isoproterenol; D002118:Calcium